Depressive symptomatology and cocaine-induced pituitary-adrenal axis activation in individuals with cocaine dependence.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Drug and Alcohol Dependence

• Publication date

  1999-08-02

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0376-8716(99)00009-5PMID 10462091
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.

  1998cited by this paper
• Blunted adrenocorticotropin and Cortisol responses to corticotropin‐releasing hormone stimulation in chronic fatigue syndrome

  1998cited by this paper
• Neurobiology of Stress and Cocaine Addiction: Studies on Corticotropin‐Releasing Factor in Rats, Monkeys, and Humans a

  1998cited by this paper
• Cocaine Tolerance: Behavioral, Cardiovascular, and Neuroendocrine Function in Men

  1998influential reference
• Neuroendocrine-Related Effects of Long-Term, ‘Binge’ Cocaine Administration: Diminished Individual Differences in Stress-Induced Corticosterone Response

  1998cited by this paper
• Concurrent pharmacokinetic analysis of plasma cocaine and adrenocorticotropic hormone in men.

  1998cited by this paper
• Plasma arginine vasopressin and motor activity in major depression.

  1998cited by this paper
• Acute effects of cocaine on human brain activity and emotion.

  1997cited by this paper
• The corticotropin-releasing hormone challenge in depressed abused, depressed nonabused, and normal control children.

  1997cited by this paper
• Cocaine's effects on neuroendocrine systems: clinical and preclinical studies.

  1997influential reference
• Chronic cocaine intoxication alters hippocampal sodium channel function.

  1997cited by this paper
• A neuroendocrine role in cocaine reinforcement.

  1997cited by this paper
• Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons.

  1996cited by this paper
• Neurobiological Actions of Cocaine in the Hippocampus a

  1996cited by this paper
• The effect of anxiety and depression on completion/withdrawal status in patients admitted to substance abuse detoxification program.

  1996cited by this paper
• Hippocampal atrophy in recurrent major depression.

  1996cited by this paper
• Brain glucose metabolism during non-rapid eye movement sleep in major depression. A positron emission tomography study.

  1996cited by this paper
• Corticotropin Releasing Hormone in the Pathophysiology of Melancholic and Atypical Depression and in the Mechanism of Action of Antidepressant Drugs

  1995cited by this paper
• Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.

  1995cited by this paper
• Intermittent cocaine exposure causes delayed and long-lasting sensitization of cocaine-induced ACTH secretion in rats.

  1995cited by this paper
• Role of oxytocin in the neuroadaptation to drugs of abuse.

  1994cited by this paper
• Cocaine effects on pulsatile secretion of ACTH in men.

  1994cited by this paper
• Monoaminergic regulation of neuroendocrine function and its modification by cocaine.

  1994cited by this paper
• Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age.

  1993cited by this paper
• Cocaine-induced stimulation of the rat hypothalamic-pituitary-adrenal axis is progressively attenuated following hourly-interval regimens of the drug.

  1992cited by this paper
• Diurnal variations in plasma ACTH, cortisol and beta-endorphin levels in cocaine addicts.

  1992cited by this paper
• Detection and confirmation of cocaine and cocaethylene in serum emergency toxicology specimens.

  1992cited by this paper
• The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis.

  1991cited by this paper
• Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression.

  1991influential reference
• CSF 5-HIAA, serum cortisol, and age differentially predict vegetative and cognitive symptoms in depression.

  1990cited by this paper
• Hippocampal damage associated with prolonged glucocorticoid exposure in primates

  1990cited by this paper
• Glucocorticoid endangerment of the hippocampus: tissue, steroid and receptor specificity.

  1990cited by this paper
• The use of immunoradiometric assay for the measurement of ACTH in human plasma.

  1990cited by this paper
• Endocrine and neurochemical actions of cocaine.

  1989cited by this paper
• HAIR ANALYSIS FOR DRUGS OF ABUSE

  1989cited by this paper
• The oCRH stimulation test before and after clinical recovery from depression.

  1988cited by this paper
• Differential regulation of brain and pituitary corticotropin-releasing factor receptors by corticosterone.

  1987cited by this paper
• Postdexamethasone plasma cortisol and beta-endorphin levels in depression: relationship to severity of illness.

  1987cited by this paper
• Neuroendocrine aspects of primary endogenous depression III. Cortisol secretion in relation to diagnosis and symptom patterns

  1987cited by this paper
• Early diurnal dexamethasone suppression test results in cocaine abuse accompanied by dysphoria.

  1986cited by this paper
• The dexamethasone suppression test, the Hamilton Depression Rating Scale and the DSM-III depression categories.

  1986cited by this paper
• The application of positron emission tomography to the study of panic disorder.

  1986cited by this paper
• Neuroendocrine Findings in Chronic Cocaine Abusers: A Preliminary Report

  1985cited by this paper
• Corticosteroid inhibition of ACTH secretion.

  1984cited by this paper
• A focal brain abnormality in panic disorder, a severe form of anxiety

  1984cited by this paper
• An Improved Diagnostic Evaluation Instrument for Substance Abuse Patients: The Addiction Severity Index

  1980cited by this paper
• Principles of competitive protein-binding assays

  1971cited by this paper

• Personalized repetitive transcranial magnetic stimulation (prtms®) for post-traumatic stress disorder (ptsd) in military combat veterans

  2023cites this paper
• BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression

  2022cites this paper
• Hypothalamic-pituitary-adrenal axis activity in post-traumatic stress disorder and cocaine use disorder

  2020cites this paper
• The impact of cocaine on adult hippocampal neurogenesis: Potential neurobiological mechanisms and contributions to maladaptive cognition in cocaine addiction disorder.

  2017cites this paper
• Aspectos neurobiológicos de la depresión en pacientes consumidores de cocaína

  2015cites this paper
• In the face of threat: neural and endocrine correlates of impaired facial emotion recognition in cocaine dependence

  2015cites this paper
• Effects of cocaine on the hypothalamic–pituitary–adrenal axis

  2014cites this paper
• Pain and suicidality: insights from reward and addiction neuroscience.

  2013cites this paper
• Persistent Increase in Hypothalamic Arginine Vasopressin Gene Expression During Protracted Withdrawal from Chronic Escalating-Dose Cocaine in Rodents

  2011cites this paper
• Gender Differences in Psychosocial Stress and in Its Relationship to Gambling Urges in Individuals with Pathological Gambling

  2010cites this paper
• Delineating the psychic structure of substance abuse and addictions: should anxiety, mood and impulse-control dysregulation be included?

  2010cites this paper
• Cocaine, Hormones, and Behavior: Clinical and Preclinical Studies

  2009cites this paper
• Biologic Commonalities between Mental Illness and Addiction.

  2009cites this paper
• Cocaine decreases plasma insulin concentrations in non‐diabetic subjects: a randomized double‐blind study

  2008cites this paper
• Substance Abuse Treatment, Prevention, and Policy Effects of Perceived Cocaine Availability on Subjective and Objective Responses to the Drug

  2007cites this paper
• Neuroendocrine abnormalities in drug abusers and HIV-infected individuals: Cortisol response to cold pressor challenge

  2006cites this paper
• Distress tolerance as a predictor of early treatment dropout in a residential substance abuse treatment facility.

  2005cites this paper
• Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress.

  2005cites this paper
• Chapter 3.7 – Stress and drug abuse

  2005cites this paper
• Deficits in plasma oxytocin responses and increased negative affect, stress, and blood pressure in mothers with cocaine exposure during pregnancy.

  2004cites this paper
• Effects of acute cortisol and cocaine administration on attention, recall and recognition task performance in individuals with cocaine dependence

  2004cites this paper
• Psychosocial Stress and the Duration of Cocaine Use in Non‐treatment Seeking Individuals with Cocaine Dependence

  2003cites this paper
• Temporal concordance of cocaine effects on mood states and neuroendocrine hormones.

  2002cites this paper
• Depressive symptoms modulate the subjective and physiological response to cocaine in humans.

  2001cites this paper
• Ultrarapid opioid detoxification: effects on cardiopulmonary physiology, stress hormones and clinical outcomes.

  2001cites this paper
• Substance Misuse

  2001cites this paper
• How does stress increase risk of drug abuse and relapse?

  2001cites this paper